Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.10% | 125.14 | 0.0% | $2517.24m | |
| BNGO | BioNano Genomics, Inc. | -11.93% | 8.05 | 0.0% | $1626.30m | |
| GILD | Gilead Sciences, Inc. | 1.37% | 67.99 | 1.0% | $696.88m | |
| AMGN | Amgen, Inc. | 1.65% | 252.36 | 1.3% | $574.64m | |
| CRSP | CRISPR Therapeutics AG | -4.30% | 189.77 | 0.6% | $516.52m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.57% | 542.27 | 2.7% | $477.27m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.61% | 157.74 | 2.0% | $471.04m | |
| NVAX | Novavax, Inc. | -2.31% | 125.05 | 92.9% | $463.88m | |
| ILMN | Illumina, Inc. | 3.42% | 403.54 | 3.5% | $395.72m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.04% | 96.76 | 13.8% | $351.95m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.07% | 236.70 | 1.9% | $351.25m | |
| BIIB | Biogen, Inc. | -1.30% | 270.28 | 1.7% | $328.68m | |
| BNTX | BioNTech SE | -1.40% | 103.23 | 0.0% | $308.28m | |
| OCGN | Ocugen, Inc. | -4.70% | 2.23 | 0.0% | $294.71m | |
| PACB | Pacific Biosciences of California, Inc. | -4.02% | 38.59 | 7.4% | $258.16m |
Company Profile
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.